Large-scale testing (Phase 3)Study completedNCT02714595
What this trial is testing
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
Who this might be right for
Healthcare-associated Pneumonia (HCAP)Bloodstream Infections (BSI)Hospital Acquired Pneumonia (HAP)+3 more
Shionogi 152